Skip to main content
. 2021 Nov 12;4(6):1818–1834. doi: 10.1021/acsptsci.1c00223

Figure 2.

Figure 2

Biochemical characterization of LSD1 inhibitors. Dose–response curves of LSD1 inhibition for tool compounds (A) and clinical stage inhibitors (B) determined with the HTRF assay. Selectivity of compounds vs other FAD-dependent enzymes (C). aValues obtained with the HTRF assay. bCompound not soluble at 100 μM. Data are represented as mean ± SD of N = 2, n = 2 or 3.